Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BACH1 controls hepatic insulin signaling and glucose homeostasis in mice. | Nat Commun | 2023 | 38129407 | PubTator, text mining | PubMed |
| Transcriptome analysis of skeletal muscle in dermatomyositis, polymyositis, and dysferlinopathy, using a bioinformatics approach. | Front Neurol | 2023 | 38125829 | PubTator, text mining | PubMed |
| Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA. | BMC Pulm Med | 2023 | 38102594 | PubTator, text mining | PubMed |
| Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA. | Front Immunol | 2023 | 38094295 | PubTator, text mining | PubMed |
| Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis. | NPJ Syst Biol Appl | 2023 | 38086828 | PubTator, text mining | PubMed |
| Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system. | Front Immunol | 2023 | 38077402 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy. | Signal Transduct Target Ther | 2023 | 38072988 | PubTator, text mining | PubMed |
| Interplay of Vitamin D, Unfolded Protein Response, and Iron Metabolism in Neuroblastoma Cells: A Therapeutic Approach in Neurodegenerative Conditions. | Int J Mol Sci | 2023 | 38069206 | PubTator, text mining | PubMed |
| Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. | Cancers (Basel) | 2023 | 38067336 | PubTator, text mining | PubMed |
| Nutrient deprivation alters the rate of COPII subunit recruitment at ER subdomains to tune secretory protein transport. | Nat Commun | 2023 | 38066006 | PubTator, text mining | PubMed |
| A review on the mechanisms underlying the antitumor effects of natural products by targeting the endoplasmic reticulum stress apoptosis pathway. | Front Pharmacol | 2023 | 38044941 | PubTator, text mining | PubMed |
| Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects. | Mol Cancer | 2023 | 38041084 | PubTator, text mining | PubMed |
| Proteomic investigations of adult polyglucosan body disease: insights into the pathobiology of a neurodegenerative disorder. | Front Neurol | 2023 | 38033781 | PubTator, text mining | PubMed |
| Antiviral activity of nitazoxanide against Morbillivirus infections. | J Virus Erad | 2023 | 38028567 | PubTator, text mining | PubMed |
| The anti-leukemia activity and mechanisms of shikonin: a mini review. | Front Pharmacol | 2023 | 38026987 | PubTator, text mining | PubMed |
| Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition. | iScience | 2023 | 38025778 | PubTator, text mining | PubMed |
| Shedding Light on the Role of ERAP1 in Axial Spondyloarthritis. | Cureus | 2023 | 38024089 | PubTator, text mining | PubMed |
| Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA. | Clin Med Insights Endocrinol Diabetes | 2023 | 38023736 | PubTator, text mining | PubMed |
| A Machine Learning-Based Classification of Immunogenic Cell Death Regulators and Characterisation of Immune Microenvironment in Acute Ischemic Stroke. | Int J Clin Pract | 2023 | 38020537 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields novel macrophage-secreted drivers of invasion. | bioRxiv | 2023 | 38014161 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=9